Unravelling the complex interplay between antibiotic consumption and adaptive changes in methicillin-resistant...

Area of Science:

• Microbiology
• Genomics
• Epidemiology

Background:

• Antimicrobial resistance (AMR) poses a significant global health threat.
• Understanding the genomic drivers of AMR is crucial for effective control strategies.
• Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital-acquired infections.

Purpose of the Study:

• To investigate the genomic dynamics of AMR emergence.
• To explore the relationship between antimicrobial usage and AMR development.
• To specifically examine the impact of glycopeptide use on MRSA resistance.

Main Methods:

• Analysis of a 12-year ST239 MRSA dataset from a single hospital.
• Genomic analysis to track population changes and resistance emergence.
• Correlation of glycopeptide usage with reduced vancomycin susceptibility.

Main Results:

• A significant correlation was found between hospital glycopeptide usage and MRSA with reduced vancomycin susceptibility.
• Genomic insights revealed molecular mechanisms of resistance, including altered molecular clock rates.
• Antimicrobial consumption directly influences the selection of resistant strains.

Conclusions:

• Hospital-level antimicrobial use significantly impacts AMR dynamics.
• Reduced vancomycin susceptibility in MRSA is linked to glycopeptide consumption.
• Antimicrobial stewardship and optimized consumption are vital for mitigating AMR.